MedTrace Logo

Dronabinol After Arthroscopic Surgery

NCT05335252 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-04-29

No results posted yet for this study

Summary

The purpose of the proposed study is to evaluate the efficacy of dronabinol for postoperative pain after arthroscopic surgery of the knee. The investigators hypothesize that dronabinol will relieve pain, reduce opioid consumption and will result in few negative side effects. If this pilot study shows promising results the investigators will expand the trial to include additional arthroscopic surgeries (hip, shoulder) and other types of orthopaedic surgery.

Conditions

  • Knee Osteoarthritis
  • Knee Injuries
  • Meniscus Tear
  • Synovitis of Knee
  • Knee Ligament Injury
  • Chondral Injury of Left Knee
  • Chondral Injury of Right Knee
  • Loose Body Knee

Interventions

DRUG

Dronabinol

5mg 2x daily for 7 days

DRUG

Placebo

1 caplet 2x daily for 7 days

Sponsors & Collaborators

Principal Investigators

  • Vehniah K Tjong, MD · Northwestern Feinberg School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-28
Primary Completion
2026-12-31
Completion
2027-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05335252 on ClinicalTrials.gov